AstraZeneca Doubles Down On Amyloidosis With Neurimmune Alliance

Fuels Ambition To Be Leading Heart Failure Firm

 
• By Kevin Grogan
  
AstraZeneca
• Source: Shutterstock: Elzbieta Krzysztof
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip